Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Pediatric Oncology
•
Medical Oncology
•
Thrombosis
•
Hematology
•
Pediatric Hematology
•
Hemostasis/Thrombosis
Does your evaluation of a young person with spontaneous upper extremity DVT vary as compared to lower extremity DVT?
Do you do additional workup for venous obstruction or any other different testing/evaluation?
Related Questions
What is the ideal period to wait until curative surgery for patients with acute pulmonary embolism and solid malignancy?
For patients with incidental findings of venous thromboembolism during workup of a treatable malignancy, how do you approach discontinuation after the treatment is complete?
For a patient with May-Thurner syndrome and DVT, would you recommend anticoagulation for 3-6 months or indefinitely?
Are there any circumstances where you would consider bridging for patients on DOACs?
In a young female with severe osteoporosis due to congenital estrogen deficiency, can estrogen be prescribed if genetic testing for congenital disorders reveals a heterozygous Factor V Leiden mutation?
Are SCDs contraindicated in patients with acute DVTs?
What is your target Hgb/Hct for women who are pregnant and have sickle cell disease in whom you are doing scheduled transfusions?
How would you adjust the steroid dose for steroid-induced psychosis in a patient being treated for secondary HLH with the HLH-94 protocol?
When do you consider indefinite anticoagulation in someone with first episode of calf vein DVT?
How would you manage a young patient with HL who develops HF (EF < 30%) after 4 cycles of A+AVD who obtained a PET2 CR?